- Home
- UI vs BNTX Comparison
UI vs BNTX Comparison
Compare UI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UI
- BNTX
- Stock Information
- Founded
- UI 2003
- BNTX 2008
- Country
- UI United States
- BNTX Germany
- Employees
- UI N/A
- BNTX N/A
- Industry
- UI Radio And Television Broadcasting And Communications Equipment
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UI Technology
- BNTX Health Care
- Exchange
- UI Nasdaq
- BNTX Nasdaq
- Market Cap
- UI 23.9B
- BNTX 26.4B
- IPO Year
- UI 2011
- BNTX 2019
- Fundamental
- Price
- UI $604.43
- BNTX $96.74
- Analyst Decision
- UI Buy
- BNTX Strong Buy
- Analyst Count
- UI 2
- BNTX 18
- Target Price
- UI $449.50
- BNTX $139.49
- AVG Volume (30 Days)
- UI 224.5K
- BNTX 1.1M
- Earning Date
- UI 11-07-2025
- BNTX 11-03-2025
- Dividend Yield
- UI 0.53%
- BNTX N/A
- EPS Growth
- UI 103.15
- BNTX N/A
- EPS
- UI 11.76
- BNTX N/A
- Revenue
- UI $2,573,545,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- UI $0.02
- BNTX N/A
- Revenue Next Year
- UI $2.56
- BNTX $15.19
- P/E Ratio
- UI $51.43
- BNTX N/A
- Revenue Growth
- UI 33.45
- BNTX 6.98
- 52 Week Low
- UI $198.08
- BNTX $81.20
- 52 Week High
- UI $621.10
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- UI 73.89
- BNTX 37.48
- Support Level
- UI $511.00
- BNTX $99.90
- Resistance Level
- UI $621.10
- BNTX $104.48
- Average True Range (ATR)
- UI 17.42
- BNTX 4.24
- MACD
- UI 7.96
- BNTX -0.47
- Stochastic Oscillator
- UI 85.36
- BNTX 26.73
About UI Ubiquiti Inc.
Ubiquiti Inc is a wireless and wireline network equipment provider for small Internet service providers and small- and midsize-business integrators. Its product is based on two primary categories namely Service Provider Technology and Enterprise Technology. The company generates maximum revenue from Enterprise Technology. Geographically, it derives a majority of revenue from North America and also has a presence in Europe, the Middle East and Africa; Asia Pacific and South America.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.